Skip to main content
. 2023 Nov 13;4:1269758. doi: 10.3389/fcdhc.2023.1269758

Figure 2.

Figure 2

Median days of graft function considering positivity or negativity for GAD65 antibodies only. In this analysis subjects seroconverters and subjects positive for IA2 were excluded (n = 29).